In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy will have the option to buy now and pay later under a partnership announced Tuesday by ...

Diabetes and weight loss treatments such as Ozempic and Wegovy, known as GLP-1 agonists, could significantly reduce the risk of developing any type of dementia, according to a meta-analysis of 26 ...

There are different GLP-1 molecules. But emerging data suggest semaglutide, the active compound in Ozempic and Wegovy, can lead to the same substantial drops in body mass index and health problems ...

A start-up which champions sustainable weight loss has landed a seven-figure sum from blue-chip backers as it seeks to capitalise on the explosive growth of prescription drugs such as Wegovy.

Semaglutide (the active ingredient in Ozempic and Wegovy) is commonly used to treat type 2 diabetes and obesity. © Starmarpro via Shutterstock The case for Ozempic ...

Novo Nordisk is considering launching its weight loss injection Wegovy in India sooner than planned to better challenge U.S. rival Eli Lilly, Reuters reports, citing unnamed sources. --The Danish ...

HYDERABAD, April 7 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better compete with ...